TNFRSF8 and classic Hodgkin lymphoma: In another phase I/II trial of an anti-CD30 CAR-T cell product in R/R cHL, 41 patients underwent lymphodepletion with different regimens of bendamustine alone, bendamustine–fludarabine or cyclophosphamide–fludarabine [52].